a public good project by the
Synthesis
Company
of California

© 2026

Akemi Kataoka | doi.page

0 works0 citations0 h-index

Akemi Kataoka

Japanese Foundation For Cancer Research(JP)

Publications by Year

Research Areas

Breast Cancer Treatment Studies, Cancer Risks and Factors, Reproductive Biology and Fertility, Breast Lesions and Carcinomas, HER2/EGFR in Cancer Research

Most-Cited Works

→ Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer(2023)205 cited
→ Activation of PI3K/Akt signaling and hormone resistance in breast cancer(2006)199 cited
→ The association between Akt activation and resistance to hormone therapy in metastatic breast cancer(2006)117 cited
→ Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry(2016)85 cited
Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.(2002)
→ Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan(2014)73 cited
→ Correlated Expression ofCD47andSIRPAin Bone Marrow and in Peripheral Blood Predicts Recurrence in Breast Cancer Patients(2010)

62 cited

→ Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy(2021)54 cited

→ Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer(2003)52 cited

Cystatin-like metastasis-associated protein mRNA expression in human colorectal cancer is associated with both liver metastasis and patient survival.(2002)